Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_assertion type Assertion NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_head.
- NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_assertion wasGeneratedBy ECO_0000203 NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_provenance.
- NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_assertion wasDerivedFrom lhgdn-20090331 NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_provenance.
- NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_assertion SIO_000772 18398952 NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_provenance.
- NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_assertion evidence source_evidence_literature NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_provenance.
- NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_assertion description "[Lack of the NAT2*4 haplotype is strongly linked to adverse effects with sulfosalazine therapy in Japanese patients with rheumatoid arthritis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236550.RAk-nChGcL6YHpoNDkYzzMMmpmiWaoVAwiOGD21-UZMJw130_provenance.